Please assess the completion status of the following clinical trial:

Trial Title: Effects of Gallopamil in Severe Asthma

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Male or female aged more than 18 years~* Written informed consent~* Diagnosis of severe asthma according to ATS criteria~Exclusion Criteria:~* Smoker or former smoker~* Chronic viral infections (hepatitis, HIV)~* Aspergillosis~* Pregnancy~* Breastfeeding~* Contraindications to gallopamil or bronchoscopy

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): 16 patients with a diagnosis of severe asthma under gallopamil treatment
- 2 (Type: PLACEBO_COMPARATOR): 16 patients with a diagnosis of severe asthma under placebo treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).